Cargando…
Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome
Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...
Autores principales: | François, Clément, Stern, John M., Ogbonnaya, Augustina, Lokhandwala, Tasneem, Landsman-Blumberg, Pamela, Duhig, Amy, Shen, Vivienne, Tan, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508372/ https://www.ncbi.nlm.nih.gov/pubmed/28740620 http://dx.doi.org/10.1080/20016689.2017.1318691 |
Ejemplares similares
-
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
por: Faulkner, Michele A
Publicado: (2015) -
Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
por: Leahy, Jennifer T, et al.
Publicado: (2011) -
Budget Impact Analysis of Antiepileptic Drugs for Lennox-Gastaut Syndrome
por: Skornicki, Michelle, et al.
Publicado: (2014) -
Lennox-Gastaut syndrome: An overview
por: Ramanathan, Ramnath Santhosh, et al.
Publicado: (2010) -
Anaesthetic management in a patient with Lennox-Gastaut syndrome
por: Dhansura, Tasneem, et al.
Publicado: (2014)